How often do GLP-1 prices change?

Faster than any static article survives. In the last twelve months alone: Lilly cut Zepbound vials (December 1, 2025), Novo launched the $149+ oral pill (January 5, 2026), and multiple compounded programs repriced around the narrowing gap. This site’s answer is structural: every figure carries a capture date (current dataset: 2026-08-09), the index re-verifies on at least a monthly cycle, movements land in the changelog, and our own errors land permanently in corrections. A price without a date is a rumor — including ours, which is why ours are dated.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

For orientation: the verified tirzepatide field spans $215 (NexLife↗) to $597 (LifeMD↗) per month all-in as of 2026-08-09 — a $382 spread for the same molecule, made of structure rather than chemistry — while the brand lane holds $449 at maintenance via Zepbound (LillyDirect↗). Coverage, where a plan grants it, outranks the whole board.

The reading rules behind every number above: figures are all-in (medication plus mandatory fees) at the maintenance dose; prepaid paths are labeled as upfront commitments; stated-not-verified flags mark claims we could not capture on a provider’s own pages; and each record carries its capture date, source link, and archive link so the answer can be checked rather than trusted. Recompute anything here from the public dataset — that reproducibility, not our word, is the warranty.

One structural fact worth carrying out of this page: the spread between the cheapest and most expensive verified way to be on the same molecule now exceeds $4,584 a year — all of it structure (memberships, tiers, wrap) rather than chemistry — while the brand lane keeps cutting underneath (Zepbound vials to $449 in December 2025, the oral pill to $149 in January 2026). In a market moving that fast, the durable skill is not knowing today’s answer but knowing how to re-derive it: all-in basis, maintenance dose, dated capture, recomputable source — the four checks the methodology formalizes.

Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.